To gain insight into this, we performed survival and correlative analyses using the datasets available from the cBioportal [27], containing RNAseq data from NSCLC tumors, and benchmarked this analysis to our dataset of IHC-stained NSCLC patient samples to assess the potential consequences of alterations in NEDD9 levels on both the RNA and protein levels. Here, NEDD9 is linked to non-small cell lung carcinoma.